---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-063494"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:42:41.541323+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Heart Test Labs obtains temporary stay of Nasdaq delisting; hearing set for June 27

## Summary
- Nasdaq delisting action stayed pending oral hearing on June 27, 2024.
- Company implemented 1-for-100 reverse stock split on May 17, 2024.
- Previously, stock closed at $0.10 or less for 10 consecutive days triggering Low Priced Stocks Rule.
- Company intends to argue it has regained compliance with Minimum Bid Price and Low Priced Stocks Rules.
- No assurance of successful appeal; shares continue trading under HSCS and HSCSW pending outcome.

## SEC filing metadata
- accession: 0000950170-24-063494
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017024063494/0000950170-24-063494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017024063494/hscs-20240516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-063494
- JSON: https://secwatch.observer/filing/0000950170-24-063494.json
- Plain text: https://secwatch.observer/filing/0000950170-24-063494.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.